Earnings Feed
Start Free
QUAKER CHEMICAL CORP·4

Jun 2, 4:51 PM ET

DOUGLAS MARK 4

Research Summary

AI-generated summary

Updated

Quaker Chemical (KWR) Director Douglas Mark Receives 2,957 Shares

What Happened

  • Douglas Mark, a director of Quaker Chemical Corp. (KWR), received a total of 2,957 shares through vesting/conversion of restricted stock units (RSUs) and company awards. On May 31, 2026, RSUs converted/settled into 1,216 shares (1,198 + 18). On June 1, 2026, he was granted/received 1,741 shares (766 + 975) as director compensation/awards. The reported share receipts are recorded at $0.00 (no cash purchase); one grant was issued to satisfy the annual chairperson retainer valued at $110,000.

Key Details

  • Transaction dates and types: May 31, 2026 — conversion/settlement of RSUs/dividend equivalents (derivative entries); June 1, 2026 — grants/awards of shares. Reported prices: $0.00 for awards; conversions/derivative entries show $0 or N/A.
  • Total shares received in this filing: 2,957 shares (1,216 from vesting/conversions + 1,741 from June 1 awards).
  • Shares owned after the transactions: not stated in the provided filing data.
  • Notable footnotes:
    • RSUs convert one-for-one into common shares (F1).
    • Some entries reflect settlement of dividend equivalent rights tied to RSU vesting (F2).
    • A grant was made to pay the annual chairperson retainer (value $110,000) and is fully vested as of grant (F3).
    • The vested RSUs were originally granted June 1, 2025 and vested 100% on May 31, 2026 (F4).
    • Additional time‑based RSUs were granted as 2026 director compensation and some vest 100% on May 31, 2027; dividend equivalents accrue on those (F5, F6).
  • Filing timeliness: Reported period ended May 31, 2026 and the Form 4 was filed June 2, 2026 — appears to be filed within the usual two‑business‑day window.

Context

  • These were vesting/conversion events and new grants (awards), not open‑market purchases or sales. Derivative/“M” entries reflect conversion/settlement of RSUs and dividend-equivalent rights rather than exercised-and-sold option transactions. Awards paid to satisfy retainer or as director compensation are routine and do not by themselves indicate a personal market view.